FILTER
FILTERED INTERVIEW RESULTS
Russell Trenary
PRESIDENT & CEO, OUTLOOK THERAPEUTICS
"If our ophthalmic bevacizumab is approved, we will potentially enhance the standard of care for patients with disorders like wet AMD, diabetic macular edema, and branch retinal vein occlusion by removing concerns related to off-label repackaged IV product."
Albert Friesen
CEO & CHAIRMAN OF THE BOARD, MEDICURE INC.
"Our recently launched e-commerce site for Marley Drug has huge potential and will be our most significant driver of growth and major source of our profits moving forward."
Olga Potapova
FOUNDER, CEO & SCIENTIFIC DIRECTOR, CURELINE
Cureline updates GBR on its global activities.
Jennifer Cannon
SVP GLOBAL HEAD OF MAMMALIAN BIOLOGICS, LONZA
"Our fixed-price, fastest DNA-to-IND program is packaged in a standardized platform to allow clients to bring a new antibody molecule to IND filing in a rapid amount of time."
Mark Egerton
CEO, QUOTIENT SCIENCES
"The focus of our integrated Translational Pharmaceutics programs is to provide the customer with a development platform capable of responding in real-time to emerging development data and maintain an overall timeline to proof of concept."
Peter DeYoung
CEO, PIRAMAL PHARMA SOLUTIONS
Piramal Pharma Solutions comments on its continued global expansion.
Manni Kantipudi & Ramesh Subramanian
CHIEF EXECUTIVE OFFICER (CEO) AND CHIEF COMMERCIAL OFFICER (CCO), ARAGEN LIFE SCIENCES
Aragen Life Sciences explains how its expansion in both India and US can benefit drug discovery companies.
Robert Bloder
CHIEF BUSINESS OFFICER, ASCENDIA PHARMACEUTICALS
"We were excited to secure equity investment from Signet Healthcare Partners and have since almost doubled in size in both our capacity and talent pool."
Will Lewis
CHAIRMAN & CEO, INSMED
"Insmed developed a drug-device combination that became the first approved therapy to treat patients with a refractory form of a rare and serious lung infection."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Latin America Petrochemicals and Chemicals 2024 - Digital Interactive
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
